Horizon Kinetics Medical ETF Rating $26.93 +0.62 (+2.36%) Closing price 05/2/2025 03:50 PM EasternExtended Trading$27.12 +0.19 (+0.71%) As of 05/2/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.68Holdings in MEDX have an aggregate rating of Moderate Buy based on 444 analyst ratings issued in the past year covering 32 companies (87.1% of the portfolio).MEDX Aggregate Price Target$26.93High Prediction$26.93Average Prediction$26.93Low Prediction$26.93Holdings in MEDX have an aggregate price target of $26.93 and a range of $26.93 to $26.93 covering 32 companies (87.1% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy15 Moderate Buy rating(s)Hold11 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 32 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings16.88%LLYEli Lilly and Company$825.10+3.9%4.9452 of 5 stars2.81$1,002.80 21.5%21Earnings ReportAnalyst ForecastNews CoverageGap Up9.32%ABBVAbbVie$198.62+2.7%4.5701 of 5 stars2.89$211.41 6.4%27Earnings ReportAnalyst ForecastAnalyst Revision6.59%AMGNAmgen$281.22-0.9%4.0982 of 5 stars2.41$308.18 9.6%22Earnings ReportAnalyst ForecastPositive NewsGap Up6.24%BMYBristol-Myers Squibb$50.56+1.9%4.6512 of 5 stars2.32$58.00 14.7%22Insider TradeAnalyst Revision5.64%AZNAstraZeneca$72.44+2.7%2.9082 of 5 stars3.10$88.00 21.5%10Earnings ReportShort Interest ↓Analyst Revision5.29%JNJJohnson & Johnson$156.09+1.1%4.6697 of 5 stars2.63$171.82 10.1%19Analyst Revision4.54%ALNYAlnylam Pharmaceuticals$259.39+1.7%4.2256 of 5 stars2.77$319.17 23.0%26Earnings ReportAnalyst DowngradeNews Coverage4.27%ALKSAlkermes$31.78+3.9%4.1878 of 5 stars2.67$38.33 20.6%12Earnings ReportAnalyst ForecastNews Coverage3.90%PFEPfizer$24.19+1.1%4.9794 of 5 stars2.53$29.17 20.6%15Earnings ReportAnalyst ForecastAnalyst Revision3.63%MRKMerck & Co., Inc.$83.14-0.1%5 of 5 stars2.59$111.13 33.7%22Insider TradeAnalyst RevisionPositive News2.74%REGNRegeneron Pharmaceuticals$605.61+2.6%4.8427 of 5 stars2.88$892.60 47.4%26Earnings ReportDividend AnnouncementAnalyst ForecastAnalyst RevisionHigh Trading Volume2.64%GSKGSK$39.04+0.7%1.2463 of 5 stars2.42$40.58 4.0%12Earnings ReportDividend Increase2.52%CRSPCRISPR Therapeutics$38.25+1.4%3.0315 of 5 stars2.48$73.11 91.1%21Upcoming EarningsPositive News2.46%BIIBBiogen$123.53+2.2%4.7159 of 5 stars2.38$195.85 58.5%32Earnings ReportAnalyst ForecastNews Coverage2.32%IONSIonis Pharmaceuticals$32.78+3.4%4.4027 of 5 stars2.65$56.67 72.9%20Earnings ReportAnalyst ForecastInsider TradeNews CoveragePositive News0.98%BEAMBeam Therapeutics$20.24+2.1%3.1326 of 5 stars3.00$49.45 144.3%14Upcoming EarningsShort Interest ↑News Coverage0.95%HLNHaleon$10.68+3.4%1.8214 of 5 stars2.38$10.95 2.5%8Upcoming EarningsShort Interest ↓News CoverageGap UpHigh Trading Volume0.74%VNDAVanda Pharmaceuticals$4.57+2.9%4.1119 of 5 stars3.00$16.50 261.1%2Upcoming EarningsShort Interest ↑Positive News0.69%REPLReplimune Group$10.01+3.8%4.1282 of 5 stars3.13$19.43 94.1%8Positive News0.68%NTLAIntellia Therapeutics$8.84+2.3%4.6741 of 5 stars2.65$36.68 315.0%20Upcoming Earnings0.66%BCYCBicycle Therapeutics$9.30+2.4%3.5924 of 5 stars2.78$26.00 179.6%9Earnings ReportAnalyst ForecastShort Interest ↓News Coverage0.61%LTRNLantern Pharma$3.54-2.2%2.5324 of 5 stars3.00$25.00 606.2%1Upcoming EarningsNews Coverage0.60%TSVT2seventy bio$5.00+0.4%1.7599 of 5 stars2.29$5.60 12.0%7Short Interest ↑News Coverage0.51%SDZNYSandoz Group$44.42+3.0%3.0009 of 5 stars2.0030.48%GALTGalectin Therapeutics$1.39+6.9%0.7817 of 5 stars2.00$11.00 691.4%10.42%GEHCGE HealthCare Technologies$70.53+4.2%4.4912 of 5 stars2.82$89.40 26.8%11Earnings ReportAnalyst ForecastBuyback AnnouncementGap UpHigh Trading Volume0.24%EDITEditas Medicine$1.64+1.2%4.1879 of 5 stars2.31$6.54 298.7%16Upcoming EarningsAnalyst UpgradeAnalyst RevisionNews Coverage0.18%VTRSViatris$8.65+2.1%1.6999 of 5 stars1.75$10.50 21.4%4Upcoming EarningsGap Up0.18%ALLOAllogene Therapeutics$1.70+0.6%3.3559 of 5 stars2.90$9.29 446.4%10Positive News0.11%PACBPacific Biosciences of California$1.13+1.8%3.0726 of 5 stars2.50$2.45 116.8%10Upcoming EarningsNews CoveragePositive News0.06%BLUEbluebird bio$3.95-2.5%3.0954 of 5 stars2.25$44.60 1,029.1%8Upcoming EarningsAnalyst Forecast0.02%MURAMural Oncology$2.64+1.1%3.1341 of 5 stars2.60$13.00 392.4%5 This page (NASDAQ:MEDX) was last updated on 5/3/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredTrump to solve American wealth loss?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredThe collapse has already startedThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MEDX Stock Free MEDX Stock Alerts